# ACUTE RADIATION-INDUCED LUNG INJURY IN THE RHESUS MACAQUE AND ITS' TREATMENT BYIPW-5371, A SMALL MOLECULE INHIBITOR OF TGF# RECEPTOR-1 KINASE

> **NIH NIH N01** · INNOVATION PATHWAYS, LLC · 2022 · $113,773

## Abstract

1.	This contract supports the development of safe and effective MCMs to mitigate and/or treat tissue injuries arising from exposure to ionizing radiation from a radiological or nuclear incident, thereby leading to a reduction in radiation-associated morbidities and mortalities.

## Key facts

- **NIH application ID:** 10661478
- **Project number:** 272201800012C-P00014-9999-1
- **Recipient organization:** INNOVATION PATHWAYS, LLC
- **Principal Investigator:** BARRY HART
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2022
- **Award amount:** $113,773
- **Award type:** —
- **Project period:** 2020-04-01 → 2023-03-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10661478

## Citation

> US National Institutes of Health, RePORTER application 10661478, ACUTE RADIATION-INDUCED LUNG INJURY IN THE RHESUS MACAQUE AND ITS' TREATMENT BYIPW-5371, A SMALL MOLECULE INHIBITOR OF TGF# RECEPTOR-1 KINASE (272201800012C-P00014-9999-1). Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/grant/nih/10661478. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*